• 1. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 2. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 3. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 4. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 5. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Methoxybenzoic acids and derivatives

Introduction to 4-Methoxy-1H-indazole-6-carboxylic acid (CAS No. 1167055-67-5)

4-Methoxy-1H-indazole-6-carboxylic acid, identified by the Chemical Abstracts Service Number (CAS No.) 1167055-67-5, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the indazole family, characterized by a fused benzene and pyridine ring system, with a methoxy group at the 4-position and a carboxylic acid moiety at the 6-position. The structural features of this molecule make it a versatile scaffold for the development of bioactive molecules, particularly in the context of drug discovery and therapeutic intervention.

The indazole core of 4-Methoxy-1H-indazole-6-carboxylic acid is a privileged structure in medicinal chemistry, known for its broad spectrum of biological activities. Indazole derivatives have been extensively studied for their potential applications in treating various diseases, including cancer, infectious diseases, and neurological disorders. The presence of the methoxy group at the 4-position and the carboxylic acid functionality at the 6-position introduces additional reactivity and binding potential, enabling further chemical modification and functionalization to tailor its pharmacological properties.

In recent years, there has been a surge in research focused on developing novel indazole-based compounds with improved pharmacokinetic profiles and enhanced therapeutic efficacy. 4-Methoxy-1H-indazole-6-carboxylic acid has emerged as a key intermediate in synthesizing more complex molecules with targeted biological activities. For instance, researchers have explored its utility in generating inhibitors of enzymes involved in cancer metabolism, such as poly(ADP-ribose) polymerases (PARPs) and tyrosine kinases. These inhibitors have shown promise in preclinical studies, demonstrating mechanisms that could lead to effective treatments for tumors with specific genetic mutations.

The carboxylic acid group in 4-Methoxy-1H-indazole-6-carboxylic acid provides a site for further derivatization, allowing chemists to introduce various functional groups that can modulate solubility, bioavailability, and target specificity. For example, esterification or amidation of the carboxylic acid can yield derivatives with improved metabolic stability or enhanced binding affinity to biological targets. Additionally, the methoxy group at the 4-position can serve as a handle for further chemical transformations, such as etherification or sulfonylation, expanding the structural diversity of indazole-based pharmacophores.

One of the most compelling aspects of 4-Methoxy-1H-indazole-6-carboxylic acid is its role in developing small-molecule probes for biochemical studies. Indazole derivatives have been employed as tools to investigate signaling pathways and enzyme mechanisms relevant to human health and disease. For instance, fluorescently labeled analogs of this compound have been used to visualize protein-protein interactions in living cells, providing insights into cellular processes that are dysregulated in pathological conditions. Such studies not only advance our understanding of disease mechanisms but also aid in identifying new therapeutic targets.

The pharmaceutical industry has also shown interest in 4-Methoxy-1H-indazole-6-carboxylic acid as a building block for drug candidates targeting neurological disorders. Indazole-based compounds have demonstrated potential in modulating neurotransmitter systems involved in conditions such as depression, anxiety, and epilepsy. Preclinical studies have indicated that derivatives of this scaffold can interact with receptors and enzymes that regulate mood and cognitive function, offering hope for novel treatments that may address unmet medical needs. The versatility of 4-Methoxy-1H-indazole-6-carboxylic acid allows for fine-tuning its pharmacological profile through structural modifications, making it an attractive candidate for further development.

From a synthetic chemistry perspective, 4-Methoxy-1H-indazole-6-carboxylic acid serves as a valuable precursor for constructing more complex indazole derivatives via multi-step organic transformations. Advances in synthetic methodologies have enabled efficient access to this compound, facilitating its use in large-scale drug discovery programs. Techniques such as palladium-catalyzed cross-coupling reactions and enzymatic resolutions have been employed to achieve high yields and purity levels necessary for pharmaceutical applications. These synthetic strategies underscore the importance of 4-Methoxy-1H-indazole-6-carboxylic acid as a cornerstone molecule in modern medicinal chemistry.

The growing body of research on indazole derivatives, including 4-Methoxy-1H-indazole-6-carboxylic acid, highlights their potential as therapeutic agents across multiple disease areas. Ongoing clinical trials are evaluating indazole-based drugs for their efficacy in treating cancer patients with specific genetic profiles. Similarly, preclinical investigations are exploring their applications in managing infectious diseases caused by resistant pathogens. The ability of these compounds to modulate key biological pathways makes them promising candidates for next-generation therapeutics that address emerging challenges in global health.

In conclusion,4-Methoxy-1H-indazole-6-carboxylic acid (CAS No. 1167055-67-5) is a structurally fascinating molecule with significant potential in pharmaceutical research and drug development. Its unique combination of functional groups and biological relevance positions it as a valuable tool for investigating disease mechanisms and designing novel therapeutics. As research continues to uncover new applications for indazole-based compounds,4-Methoxy-1H-indazole-6-carboxylic acid is likely to remain at the forefront of medicinal chemistry innovation.

• 633327-84-1(4-甲氧基吲唑-5-甲酸乙酯)
• 1408074-52-1(Methyl 4-hydroxy-1H-indazole-6-carboxylate)
• 885521-13-1(Methyl 4-methoxy-1H-indazole-6-carboxylate)
• 1131605-20-3(7-Hydroxy-1H-indazole-5-carboxylic acid)
• 633327-83-0(4-methoxy-1H-indazole-5-carboxylic acid)
• 1197943-41-1(7-Methoxy-1H-indazole-5-carboxylic acid)
• 574758-53-5(6-Hydroxy-1H-indazole-5-carboxylic acid)
• 65362-03-0(1H-INDAZOLE, 6-METHYL-4-(PHENYLMETHOXY)-)
• 1197944-11-8(7-Ethoxy-1H-indazole-5-carboxylic acid)
• 1082041-60-8(6-Methoxy-1H-indazole-5-carboxylic acid)